Showing results (51-60 of 200) with videos related to
Sort By:
Pageof 20
Head & Neck|September 20, 2011
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancerPingdong Li, Chun-Hao Chen, Sen Li, et al.Cancer|February 23, 2021
Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safetyCasey W Williamson, Michael V Sherer, Dmitriy Zamarin, et al.Gynecologic Oncology|August 23, 2025
Early-stage uterine papillary serous carcinoma: Clinical outcomes in patients treated with adjuvant chemotherapy and vaginal brachytherapyDaniel R Cherry, Vishal Gupta, Julie R Bloom, et al.Nature Communications|February 15, 2017
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunityDmitriy Zamarin, Rikke B Holmgaard, Jacob Ricca, et al.Molecular Cancer Therapeutics|September 23, 2010
Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesotheliomaGerd R Silberhumer, Peter Brader, Joyce Wong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I StudyDmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor, et al.Methods in Molecular Biology (Clifton, N.J.)|February 11, 2017
Validation of Anti-Mouse PDL-1 Goat Polyclonal Antibody Staining with Mouse PDL-1 In Situ Hybridization on Adjacent Sections of Cell Pellets and Mouse TumorsJacob Ricca, Mesruh Turkekul, Afsar Barlas, et al.Science Immunology|August 2, 2017
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cellsPeihong Dai, Weiyi Wang, Ning Yang, et al.Journal of Virology|August 17, 2005
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificityLaurel Glaser, James Stevens, Dmitriy Zamarin, et al.Science Translational Medicine|March 7, 2014
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapyDmitriy Zamarin, Rikke B Holmgaard, Sumit K Subudhi, et al.Pageof 20